Cardiology blend | Cholesterol management
- Bifidobacterium lactis – MB2409 (DSM 23733)
- Bifidobacterium bifidum – MB109 (DSM 23731)
- Bifidobacterium longum – 04 (DSM 23233)
Characteristics
DAILY DOSAGE IN CLINICAL STUDY
1 billion CFU/strain
FUNCTIONALITY
Cardiovascular health • Cholesterol lowering
Scientific support
Human clinical trial
Guardamagna O. et al. Bifidobacteria supplementation: effects on plasma lipid profile in dyslipidemic children. Nutrition (2014), doi: 10.1016/ j.nut. 2014.01.014.
In vitro and in vivo testing
Bordoni et al. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of Bifidobacteria. Appl. Microbiol. Biotechnol. 2013. 97:8273-8281.
Dietetics strain | Weight management
Characteristics
DAILY DOSAGE
1 billion CFU
FUNCTIONALITY
Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cholesterol management
Scientific support
Internal data available upon request
Gut-brain blend | Mood and sleep quality
- Bifidobacterium longum – 04 (DSM 23233)
- Lactobacillus fermentum – LF16 (DSM 26856)
- Lactobacillus plantarum – LP01 (LMG P-21021)
- Lactobacillus rhamnosus – LR06 (DSM 21981)
Characteristics
DAILY DOSAGE IN CLINICAL STUDY
1 billion cfu/afu per strain
FUNCTIONALITY
Improvement of the quality of sleep • Reduction of fatigue and anger • Improvement of mood • Inhibition of E. coli and Candida
Scientific support
Human clinical trial
Marotta A. et al., Effects of Probiotics on Cognitive Reactivity, Mood, and Sleep Quality, 2019 Frontiers in Psychiatry.
